September
was a very busy month with lots of good research papers and systematic reviews
published on various topics. We also saw many guidelines and recommendations
updates from ACOG, ASRM and USPSTF. Here are the top 5 most read posts for the
month of September.
USPSTF simplifies cervical cancer
screening recommendations: Dual testing no longer advised
The US
Preventive Services Task Force (USPSTF) has issued new draft recommendations for cervical cancer
screening with a major change that it recommends either cervical cytology (CC)
or high-risk HPV (hrHPV) test as a screening procedure every 3 years for women
aged 30-65 years, and not both ( Grade A)
ACOG issues clinical practice
guidelines for Gestational Diabetes Mellitus
The American
College of Obstetricians and Gynecologists (ACOG) has issued clinical practice guidelines for the diagnosis and
treatment of gestational diabetes mellitus (GDM).
Although
prevalence of GDM is directly proportional to prevalence of type 2 DM in a
given population, it is estimated that GDM accounts for 90% of cases diabetes
in pregnancy. The prevalence of DM in pregnancy is around 6-9%.
ASRM guidelines update: Metformin
alone is not the first line of treatment for ovulation induction in women with
PCOS
Practice
Committee of the American Society for Reproductive Medicine does not recommend
Metformin alone for ovulation induction as a first line therapy in women with
PCOS. The guidelines were published in Journal Fertility and Sterility Epub
ahead of print.
Metformin is
a biguanide used as an oral insulin lowering agent in type2 diabetes, but also
used enthusiastically in women with PCOS because of shared pathophysiology of
insulin resistance in both.
Oral Nifedipine parallels IV
hydralazine in lowering down BP in acute hypertensive emergency in pregnancy
Intravenous
hydralazine and oral nifedipine both exhibit the same efficacy in lowering the
blood pressure in acute hypertensive emergency of pregnancy reports the results
of small randomized trial published online in journal American
Journal of Obstetrics and Gynecology.
Oral diclofenac potassium plus
cervical lidocaine cream eases the pain during hysterosalpingography
Oral
diclofenac potassium tab 30 minutes before hysterosalpingography (HSG) and
cervical lidocaine cream 5% significantly relieves pain and eases patient
anxiety during the procedure and for half an hour after reports the results of
a randomized trial published in September issue of journal Fertility
and Sterility.
No comments:
Post a Comment